About TruPeptide

TruPeptide exists to give people clear, honest, independent information about peptide compounds, the clinics and vendors that provide them, and the regulatory landscape that governs them.

We don't sell peptides. We don't take money from vendors or clinics to influence what we say about them. We don't have a position on whether peptides are good or bad — we have a position on whether information is accurate or not.

In a space defined by commercial bias, regulatory confusion, and a gray market built on the absence of trustworthy alternatives, we're building the resource we wish already existed: transparent, data-driven, and accountable to no one but the people who use it.

What We Cover

Peptide Database

Compound profiles with mechanism, uses, risks, and FDA status for 17+ compounds.

FDA Status Tracker

Real-time regulatory status, PCAC timeline, and plain-English breakdowns of every major FDA action.

Clinic Directory

Licensed telehealth providers with trust scores, pricing, and peptide catalogs.

Vendor Directory

Research suppliers with COA-based trust scores and purity data.

Articles & Research

Regulatory guides, compound explainers, and safety information.

Our Principles

No affiliate commissions

We don't earn money when you click through to a vendor or clinic. Our trust scores and rankings cannot be bought.

Transparent methodology

Every trust score is calculated from documented criteria — COA verification, lab testing, reviews, and operational transparency. The methodology is published on each directory page.

Regulatory accuracy

FDA status changes rapidly. We update the tracker as events happen and clearly distinguish between what's authorized, what's in a gray zone, and what's restricted.

No vendor sponsorships

No vendor or clinic pays for placement, improved rankings, or editorial coverage. Listings are based on publicly available information.

Evidence-based content

Articles cite primary sources. We distinguish between animal research and human clinical data. We include the skeptical view alongside the evidence.

Why This Exists

The peptide space has almost no trustworthy consumer-facing information. Vendor blogs have obvious commercial interests. Affiliate review sites rank whoever pays the most. Reddit communities have real knowledge but no editorial standards. PubMed has the research but isn't accessible to most people. The FDA has authoritative information but it's not designed for patients trying to understand their options.

The gap between "vendor marketing" and "academic paper" is enormous. TruPeptide lives in that gap.

We launched in April 2026 — during the most significant regulatory shift in the peptide space in years. The FDA's April 15 announcement removing 12 peptides from the Category 2 restricted list, combined with PCAC advisory meetings scheduled for July 2026, created a moment where clear, independent information was more needed than ever. That's when we went live.

What We Are Not

  • We are not a medical provider and do not give medical advice.
  • We do not sell, distribute, or facilitate the purchase of any peptides.
  • We are not affiliated with any vendor, clinic, or compounding pharmacy.
  • We do not have a position on whether any specific peptide is safe or effective — we report what the research says.
  • We are not a regulatory body and our FDA status information, while carefully maintained, should be verified with official sources before making clinical or business decisions.

Questions, corrections, or feedback?

Submit FeedbackSubscribe to the newsletter